查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067477

多重PCR檢測市場規模、佔有率和趨勢分析報告：按疾病、檢測環境、處理能力、最終用途、地區和細分市場預測（2026-2033年）

Multiplex PCR Panel Testing Market Size, Share & Trends Analysis Report By Disease Application, By Testing Setting, By Throughput, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

多重PCR檢測市場概述

全球多重PCR檢測市場預計到2025年價值25.8億美元，預計到2033年將達到48.6億美元，2026年至2033年的複合年成長率為8.42%。

呼吸道和消化器官系統感染疾病的日益普遍，以及感染疾病診斷中對快速綜合症檢測的強烈需求，推動了市場成長。

此外，多重PCR技術、檢查室自動化和高通量分子診斷工作流程的進步正在推動多重PCR檢測在醫療機構中的廣泛應用。分散式和照護現場（POC​​）分子診斷平台的日益普及也進一步促進了市場成長。

呼吸道和消化器官系統感染疾病的日益普及推動了市場成長，而這又源於對快速、準確病原體鑑定需求的不斷成長。多重PCR檢測板能夠從單一檢體同時檢測多種病毒、細菌和寄生蟲病原體，是處理具有重疊臨床症狀的感染疾病的理想選擇。除了流感、呼吸道合胞病毒（RSV）、肺炎和其他下呼吸道感染等呼吸道感染疾病的發生率不斷上升外，諾羅病毒和志賀桿菌感染疾病感染疾病的爆發也加速了醫院和臨床檢查室採用基於症候群的分子診斷技術。根據2024年9月發表在《柳葉刀》上的一項研究，對「全球疾病負擔」的分析估計，下呼吸道感染疾病在全球整體約佔3.44億例，並且仍然是全球感染疾病相關死亡的主要原因之一。此外，2026 年 4 月，美國疾病管制與預防中心 (CDC) 報告稱，雖然美國每年發生近 2,500 起諾羅病毒疫情，但諾羅病毒每年仍導致全球約 6.85 億例急性腸胃炎病例。

由於需要更快、更全面地檢測病原體，感染疾病診斷中對快速症候群檢測的需求日益成長，推動了市場成長。症候群多重PCR檢測板能夠從單一患者檢體中同時識別與相似臨床症狀相關的多種病原體，與傳統培養和單標靶檢測相比，顯著縮短了診斷時間。醫療專業人員正在採用快速綜合症檢測來改善早期診斷、患者分診、感染控制和治療方法方案，尤其是在呼吸道、胃腸道、血液和中樞神經系統感染疾病。臨床上日益重視合理使用抗生素和減少不必要的抗生素使用，進一步推動了醫院、急診和臨床檢查室對多重症候群分子診斷技術的應用。

多重檢測和檢查室自動化技術的不斷進步，透過提高檢測效率、實現工作流程自動化和提升診斷準確性，正推動市場成長。高通量多重檢測、自動化樣本製備、整合分子系統和即時數據分析的創新，使得在更短的檢測週期和更少的人工干預下，能夠同時檢測多種病原體。這些技術也有助於提高檢查室的處理能力，並提升臨床環境中的營運效率。例如，2026年1月，Cefeid公司的Xpert GI Panel獲得了FDA的批准。此多重PCR檢測旨在從單一糞便檢體中同時檢測11種胃腸道細菌、病毒和寄生蟲病原體。此檢測利用了Cefeid公司基於GeneXpert系統的10色多重技術，支援快速綜合症檢測和自動化分子診斷工作流程。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：多重PCR檢測市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析

第4章：多重PCR檢測市場：疾病特異性商業分析

  • 按疾病分類的市場佔有率（2025 年和 2033 年）
  • 特定疾病市場規模、預測與趨勢分析（2021-2033）
  • 呼吸系統面板
  • 消化系統面板
  • 性行為感染感染（STI）小組
  • 血流/膿毒症檢查
  • 中樞神經系統（CNS）專家小組
  • 熱帶病專家組
  • 其他面板

第5章：多重PCR檢測市場：依最終用途分類的商業分析

  • 按最終用途分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測和趨勢分析：按最終用途分類，2021-2033 年
  • 醫院和診所
  • 診斷檢查室（中心檢查室）
  • 門診部
  • 學術研究機構
  • 公共衛生研究所
  • 臨床檢查室（POLs）
  • 照護端環境

第6章 多重PCR檢測市場：檢測環境下的商業分析

  • 測試環境市場佔有率（2025 年和 2033 年）
  • 按測試環境分類的市場規模、預測與趨勢分析（2021年至2033年）
  • 深入檢查
  • 患者側檢查
  • 其他

第7章 多重PCR檢測市場：基於通量的商業分析

  • 按加工能力分類的市場佔有率（2025 年和 2033 年）
  • 2021年至2033年按加工能力分類的市場規模、預測與趨勢分析
  • 低吞吐量系統（POC）
  • 中等通量系統
  • 高通量實驗室系統

第8章 多重PCR檢測市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介列表
    • F. Hoffmann-La Roche Ltd.
    • bioMerieux SA
    • QIAGEN NV
    • Thermo Fisher Scientific Inc.
    • DiaSorin SpA
    • Abbott
    • BD
    • AusDiagnostics
    • Bio-Rad Laboratories Inc.
    • Cepheid
Product Code: GVR-4-68040-918-3

Multiplex PCR Panel Testing Market Summary

The global multiplex PCR panel testing market size was estimated at USD 2.58 billion in 2025 and is projected to reach USD 4.86 billion by 2033, registering a CAGR of 8.42% from 2026 to 2033. The market growth is driven by the growing prevalence of respiratory and gastrointestinal infections and strong demand for rapid syndromic testing in infectious disease diagnostics.

Moreover, advancements in multiplexing technologies, laboratory automation, and high-throughput molecular workflows are supporting broader adoption of multiplex PCR panels across healthcare settings. Expanding utilization of decentralized and point-of-care molecular diagnostic platforms is further contributing to market growth.

The rising prevalence of respiratory and gastrointestinal infections is driving market growth due to growing demand for rapid and accurate pathogen identification. Multiplex PCR panel enables simultaneous detection of multiple viral, bacterial, and parasitic pathogens from a single sample, making them well-suited for managing infections associated with overlapping clinical symptoms. The growing incidence of respiratory infections, including influenza, RSV, pneumonia, and other lower respiratory tract infections, along with outbreaks of gastrointestinal infections such as norovirus and Shigella, is accelerating the adoption of syndromic molecular diagnostics across hospitals and clinical laboratories. According to a study published in The Lancet in September 2024, Global Burden of Disease analyses estimated that lower respiratory infections accounted for approximately 344 million cases globally and continued to rank among the leading infectious causes of mortality worldwide. Moreover, the Centers for Disease Control and Prevention reported in April 2026 that nearly 2,500 norovirus outbreaks occur annually in the U.S., while norovirus continues to cause approximately 685 million cases of acute gastroenteritis globally each year.

The growing demand for rapid syndromic testing in infectious disease diagnostics is supporting market growth due to the need for faster and more comprehensive pathogen detection. Syndromic multiplex PCR panel enables simultaneous identification of multiple pathogens associated with similar clinical symptoms from a single patient sample, reducing diagnostic turnaround time compared with conventional culture-based and single-target testing methods. Healthcare providers are adopting rapid syndromic testing to improve early diagnosis, patient triage, infection control, and treatment selection, particularly in respiratory, gastrointestinal, bloodstream, and central nervous system infections. The growing clinical emphasis on antimicrobial stewardship and reduction of unnecessary antibiotic use is further supporting the adoption of multiplex syndromic molecular diagnostics across hospitals, emergency departments, and clinical laboratories.

Continuous advancements in multiplexing and laboratory automation technologies are driving market growth by improving testing efficiency, workflow automation, and diagnostic accuracy. Innovations in high-plex assay development, automated sample preparation, integrated molecular systems, and real-time data analysis are enabling simultaneous detection of multiple pathogens with faster turnaround times and minimal hands-on time. These technologies also support higher laboratory throughput and improved operational efficiency in clinical settings. For instance, in January 2026, Cepheid received U.S. FDA clearance for the Xpert GI Panel, a multiplex PCR assay designed for simultaneous detection of 11 gastrointestinal bacterial, viral, and parasitic pathogens from a single stool sample. The panel utilizes Cepheid's 10-color multiplexing technology on GeneXpert systems, supporting rapid syndromic testing and automated molecular diagnostic workflows.

Global Multiplex PCR Panel Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global multiplex PCR panel testing market report based on disease application, end use, throughput, testing setting, and region:

  • Disease Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory Panel
  • Gastrointestinal Panel
  • Sexually Transmitted Infection (STI) Panel
  • Bloodstream / Sepsis Panel
  • Central Nervous System (CNS) Panel
  • Tropical Disease Panel
  • Other Panel
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics (dominant)
  • Diagnostic Laboratories (central labs)
  • Ambulatory Care Centers
  • Academic & Research Institutes
  • Public Health Laboratories
  • Physician Office Labs (POLs)
  • Point-of-Care Settings
  • Testing Setting Outlook (Revenue, USD Million, 2021 - 2033)
  • Centralized Laboratory Testing
  • Near-Patient Testing
  • Others
  • Throughput Outlook (Revenue, USD Million, 2021 - 2033)
  • Low-throughput systems (POC)
  • Medium-throughput systems
  • High-throughput lab systems
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease Application
    • 1.2.2. End Use
    • 1.2.3. Testing Setting
    • 1.2.4. Throughput
    • 1.2.5. Regional
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Multiplex PCR Panel Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of respiratory and gastrointestinal infections
      • 3.2.1.2. Increasing demand for rapid syndromic testing in infectious disease diagnostics
      • 3.2.1.3. Continuous advancements in multiplexing and laboratory automation technologies
      • 3.2.1.4. Growing adoption of decentralized and point-of-care molecular diagnostic platforms
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of multiplex PCR instruments and testing panel
      • 3.2.2.2. Limited reimbursement coverage and regulatory complexities for molecular diagnostic testing
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Multiplex PCR Panel Testing Market: Disease Application Business Analysis

  • 4.1. Disease Application Market Share, 2025 & 2033
  • 4.2. Disease Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease Application, 2021 to 2033 (USD Million)
  • 4.4. Respiratory Panel
    • 4.4.1. Respiratory Panel Market, 2021 - 2033 (USD Million)
  • 4.5. Gastrointestinal Panel
    • 4.5.1. Gastrointestinal Panel Market, 2021 - 2033 (USD Million)
  • 4.6. Sexually Transmitted Infection (STI) Panel
    • 4.6.1. Sexually Transmitted Infection (STI) Panel Market, 2021 - 2033 (USD Million)
  • 4.7. Bloodstream / Sepsis Panel
    • 4.7.1. Bloodstream / Sepsis Panel Market, 2021 - 2033 (USD Million)
  • 4.8. Central Nervous System (CNS) Panel
    • 4.8.1. Central Nervous System (CNS) Panel Market, 2021 - 2033 (USD Million)
  • 4.9. Tropical Disease Panel
    • 4.9.1. Tropical Disease Panel Market, 2021 - 2033 (USD Million)
  • 4.10. Other Panel
    • 4.10.1. Other Panel Market, 2021 - 2033 (USD Million)

Chapter 5. Multiplex PCR Panel Testing Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2025 & 2033
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • 5.5. Diagnostic Laboratories (central labs)
    • 5.5.1. Diagnostic Laboratories (central labs) Market, 2021 - 2033 (USD Million)
  • 5.6. Ambulatory Care Centers
    • 5.6.1. Ambulatory Care Centers Market, 2021 - 2033 (USD Million)
  • 5.7. Academic & Research Institutes
    • 5.7.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 5.8. Public Health Laboratories
    • 5.8.1. Public Health Laboratories Market, 2021 - 2033 (USD Million)
  • 5.9. Physician Office Labs (POLs)
    • 5.9.1. Physician Office Labs (POLs) Market, 2021 - 2033 (USD Million)
  • 5.10. Point-of-Care Settings
    • 5.10.1. Point-of-Care Settings Market, 2021 - 2033 (USD Million)

Chapter 6. Multiplex PCR Panel Testing Market: Testing Setting Business Analysis

  • 6.1. Testing Setting Market Share, 2025 & 2033
  • 6.2. Testing Setting Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Testing Setting, 2021 to 2033 (USD Million)
  • 6.4. Centralized Laboratory Testing
    • 6.4.1. Centralized Laboratory Testing Market, 2021 - 2033 (USD Million)
  • 6.5. Near-Patient Testing
    • 6.5.1. Near-Patient Testing Market, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Multiplex PCR Panel Testing Market: Throughput Business Analysis

  • 7.1. Throughput Market Share, 2025 & 2033
  • 7.2. Throughput Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Throughput 2021 to 2033 (USD Million)
  • 7.4. Low-throughput systems (POC)
    • 7.4.1. Low-throughput systems (POC) 2021 - 2033 (USD Million)
  • 7.5. Medium-throughput systems
    • 7.5.1. Medium-throughput systems 2021 - 2033 (USD Million)
  • 7.6. High-throughput lab systems
    • 7.6.1. High-throughput lab systems 2021 - 2033 (USD Million)

Chapter 8. Multiplex PCR Panel Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Multiplex PCR Panel Testing Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Framework
      • 8.4.2.5. U.S. Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Framework
      • 8.4.3.5. Canada Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Framework
      • 8.4.4.5. Mexico Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Framework
      • 8.5.2.5. UK Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Framework
      • 8.5.3.5. Germany Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Framework
      • 8.5.4.5. France Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Framework
      • 8.5.5.5. Italy Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Framework
      • 8.5.6.5. Spain Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Framework
      • 8.5.7.5. Denmark Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Target Disease Prevalence
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement Framework
      • 8.5.8.5. Sweden Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Target Disease Prevalence
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement Framework
      • 8.5.9.5. Norway Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Framework
      • 8.6.2.5. Japan Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Framework
      • 8.6.3.5. China Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Framework
      • 8.6.4.5. India Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Framework
      • 8.6.5.5. Australia Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement Framework
      • 8.6.6.5. South Korea Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Target Disease Prevalence
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement Framework
      • 8.6.7.5. Thailand Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Framework
      • 8.7.2.5. Brazil Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Framework
      • 8.7.3.5. Argentina Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Target Disease Prevalence
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement Framework
      • 8.8.2.5. South Africa Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Target Disease Prevalence
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement Framework
      • 8.8.3.5. Saudi Arabia Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Target Disease Prevalence
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement Framework
      • 8.8.4.5. UAE Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Target Disease Prevalence
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement Framework
      • 8.8.5.5. Kuwait Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. F. Hoffmann-La Roche Ltd.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. bioMerieux SA
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. QIAGEN N.V.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Thermo Fisher Scientific Inc.
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. DiaSorin S.p.A
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Abbott
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. BD
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. AusDiagnostics
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Bio-Rad Laboratories Inc.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Cepheid
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global multiplex PCR panel testing market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 5 Global multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 6 Global multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 7 Global multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 8 North America multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
  • Table 9 North America multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 10 North America multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 11 North America multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 12 North America multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 13 U.S multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 14 U.S multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 15 U.S multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 16 U.S multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 17 Canada multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 18 Canada multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 19 Canada multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 20 Canada multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 21 Mexico multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 22 Mexico multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 23 Mexico multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 24 Mexico multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 25 Europe multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
  • Table 26 Europe multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 27 Europe multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 28 Europe multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 29 Europe multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 30 UK multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 31 UK multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 32 UK multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 33 UK multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 34 Germany multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 35 Germany multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 36 Germany multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 37 Germany multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 38 France multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 39 France multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 40 France multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 41 France multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 42 Italy multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 43 Italy multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 44 Italy multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 45 Italy multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 46 Spain multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 47 Spain multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 48 Spain multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 49 Spain multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 50 Norway multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 51 Norway multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 52 Norway multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 53 Norway multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 54 Denmark multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 55 Denmark multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 56 Denmark multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 57 Denmark multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 58 Sweden multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 59 Sweden multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 60 Sweden multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 61 Sweden multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 67 Japan multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 68 Japan multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 69 Japan multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 70 Japan multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 71 China multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 72 China multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 73 China multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 74 China multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 75 India multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 76 India multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 77 India multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 78 India multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 79 Australia multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 80 Australia multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 81 Australia multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 82 Australia multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 83 South Korea multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 84 South Korea multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 85 South Korea multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 86 South Korea multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 87 Thailand multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 88 Thailand multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 89 Thailand multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 90 Thailand multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 91 Latin America multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
  • Table 92 Latin America multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 93 Latin America multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 94 Latin America multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 95 Latin America multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 96 Brazil multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 97 Brazil multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 98 Brazil multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 99 Brazil multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 100 Argentina multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 101 Argentina multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 102 Argentina multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 103 Argentina multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 109 South Africa multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 110 South Africa multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 111 South Africa multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 112 South Africa multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 117 UAE multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 118 UAE multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 119 UAE multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 120 UAE multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
  • Table 121 Kuwait multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
  • Table 123 Kuwait multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
  • Table 124 Kuwait multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Multiplex PCR panel testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Multiplex PCR panel testing market dynamics
  • Fig. 11 Multiplex PCR panel testing market: Porter's five forces analysis
  • Fig. 12 Multiplex PCR panel testing market: PESTLE analysis
  • Fig. 13 Multiplex PCR panel testing market: Disease application movement analysis)
  • Fig. 14 Respiratory panel market, 2021 - 2033 (USD Million)
  • Fig. 15 Gastrointestinal panel market, 2021 - 2033 (USD Million)
  • Fig. 16 Sexually transmitted infection (STI) Panel market, 2021 - 2033 (USD Million)
  • Fig. 17 Bloodstream / Sepsis Panel market, 2021 - 2033 (USD Million)
  • Fig. 18 Central Nervous System (CNS) Panel market, 2021 - 2033 (USD Million)
  • Fig. 19 Tropical Disease Panel market, 2021 - 2033 (USD Million)
  • Fig. 20 Other Panel market, 2021 - 2033 (USD Million)
  • Fig. 21 Multiplex PCR panel testing market: End use movement analysis)
  • Fig. 22 Hospitals & Clinics market, 2021 - 2033 (USD Million)
  • Fig. 23 Diagnostic Laboratories (central labs) market, 2021 - 2033 (USD Million)
  • Fig. 24 Ambulatory Care Centers market, 2021 - 2033 (USD Million)
  • Fig. 25 Academic & Research Institutes market, 2021 - 2033 (USD Million)
  • Fig. 26 Public Health Laboratories market, 2021 - 2033 (USD Million)
  • Fig. 27 Physician Office Labs (POLs) market, 2021 - 2033 (USD Million)
  • Fig. 28 Point-of-Care Settings market, 2021 - 2033 (USD Million)
  • Fig. 29 Multiplex PCR panel testing market: Setting location movement analysis
  • Fig. 30 Centralized Laboratory Testing market, 2021 - 2033 (USD Million)
  • Fig. 31 Near-Patient Testing market, 2021 - 2033 (USD Million)
  • Fig. 32 Others market, 2021 - 2033 (USD Million)
  • Fig. 33 Multiplex PCR panel testing market: Throughput movement analysis
  • Fig. 34 Low-throughput systems (POC) market, 2021 - 2033 (USD Million)
  • Fig. 35 Medium-throughput systems market, 2021 - 2033 (USD Million)
  • Fig. 36 High-throughput lab systems market, 2021 - 2033 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. country dynamics
  • Fig. 40 U.S. Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 41 Canada country dynamics
  • Fig. 42 Canada Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico country dynamics
  • Fig. 44 Mexico Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 45 Europe Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 46 UK country dynamics
  • Fig. 47 UK Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 48 Germany country dynamics
  • Fig. 49 Germany Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 50 France country dynamics
  • Fig. 51 France Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 52 Italy country dynamics
  • Fig. 53 Italy Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 54 Spain country dynamics
  • Fig. 55 Spain Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden country dynamics
  • Fig. 59 Sweden Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 60 Denmark country dynamics
  • Fig. 61 Denmark Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 62 Asia Pacific Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 63 Japan country dynamics
  • Fig. 64 Japan Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 65 China country dynamics
  • Fig. 66 China Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 67 India country dynamics
  • Fig. 68 India Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 69 Australia country dynamics
  • Fig. 70 Australia Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 71 South Korea country dynamics
  • Fig. 72 South Korea Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 73 Thailand country dynamics
  • Fig. 74 Thailand Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 76 Brazil country dynamics
  • Fig. 77 Brazil Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 78 Argentina country dynamics
  • Fig. 79 Argentina Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 80 MEA Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 81 South Africa country dynamics
  • Fig. 82 South Africa Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 83 Saudi Arabia country dynamics
  • Fig. 84 Saudi Arabia Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 85 UAE country dynamics
  • Fig. 86 UAE Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 87 Kuwait country dynamics
  • Fig. 88 Kuwait Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
  • Fig. 89 Company categorization
  • Fig. 90 Company market position analysis
  • Fig. 91 Strategic framework